Physician

Mike S. Shin, MD

According to 2025 Medicare claims, Mike Shin, MD (NPI: 1992791495) practices otolaryngology in the Hanford-Corcoran, CA market, with the plurality of this provider's patient population coming from Kings, CA. This provider's primary affiliated billing organization is MIKE S. SHIN M.D. INC (NPI: 1497987143; TIN: 270258394) and primary practice location at 93230-4926.

Shin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 507 traditional Medicare patients, billed 1,962 HCPCS/CPT codes, and received $167,277 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 468 prescription claims across 188 beneficiaries totaling $8,539 in drug costs, led by Neomycin-Polymyxin-Hc (Neomycin/Polymyxin B/Hydrocort). DME data shows 12 claims. Open Payments data shows 10 records totaling $384. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $93,748 to $8,539. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $2,606 and ending at $3,110.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	450	1,585	$144,915
2016	472	1,613	$127,205
2017	501	1,716	$149,942
2018	559	2,014	$145,014
2019	599	2,255	$172,674
2020	435	1,626	$107,743
2021	441	1,734	$136,283
2022	486	1,882	$156,228
2023	515	1,970	$177,552
2024	507	1,962	$167,277

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	123	307	$93,748
2016	129	282	$86,752
2017	160	376	$8,304
2018	159	382	$48,932
2019	181	456	$59,933
2020	134	309	$9,834
2021	159	359	$9,559
2022	175	398	$8,979
2023	175	372	$10,194
2024	188	468	$8,539

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	27	$311
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	12	$888

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	214	272	$93
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	198	198	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	248	372	$69
92557	Comprehensive hearing and speech recognition test	212	216	$28
92567	Test to assess middle ear function	234	242	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	32	989	$1,846
Ipratropium Bromide	Ipratropium Bromide	34	1,670	$944
Cefprozil	Cefprozil	37	299	$894
Fluocinolone Acetonide Oil	Fluocinolone Acetonide Oil	18	572	$835
Omeprazole	Omeprazole	102	4,440	$674

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0470	Respiratory assist device, bi-level pressure capability, without backup rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)	Y	N/R	12	$888

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	10	$384	Optinose US, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mike S. Shin, MD?

Tedicare shows public-source Medicare data for Mike S. Shin, MD (NPI 1992791495), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mike S. Shin, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mike S. Shin, MD?

Mike S. Shin, MD is linked to MIKE S. SHIN M.D. INC (billing NPI 1497987143) in the available physician profile data.

Does Mike S. Shin, MD have Open Payments data?

Mike S. Shin, MD has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.